立方制药
(003020)
| 流通市值：28.69亿 | | | 总市值：38.84亿 |
| 流通股本：1.69亿 | | | 总股本：2.28亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 226,877,499.7 | 285,062,123.74 | 413,893,621.67 | 402,570,486.96 |
| 交易性金融资产 | 325,584,102.48 | 200,526,320.56 | 40,270,405.02 | 106,849.61 |
| 应收票据及应收账款 | 357,400,696.43 | 434,758,849.23 | 452,439,172.94 | 352,582,593.76 |
| 其中：应收票据 | - | - | 0 | - |
| 应收账款 | 357,400,696.43 | 434,758,849.23 | 452,439,172.94 | 352,582,593.76 |
| 应收款项融资 | 39,570,646.22 | 53,242,281.56 | 35,059,892.79 | 38,383,754.77 |
| 预付款项 | 16,039,757.6 | 18,570,941.37 | 15,118,020.22 | 28,969,999.7 |
| 其他应收款合计 | 5,784,482.62 | 4,790,673.9 | 4,622,142.25 | 9,090,541.14 |
| 存货 | 249,186,960.18 | 227,631,684.81 | 204,499,266.78 | 270,069,733.88 |
| 一年内到期的非流动资产 | - | - | - | 80,597,942.1 |
| 其他流动资产 | 16,123,385.41 | 12,050,085.19 | 10,336,296.88 | 6,780,088.16 |
| 流动资产合计 | 1,236,567,530.64 | 1,236,632,960.36 | 1,176,238,818.55 | 1,189,151,990.08 |
| 非流动资产: | | | | |
| 长期股权投资 | 148,928,784.79 | 185,494,586.25 | 177,331,576.31 | 173,646,378.66 |
| 其他权益工具投资 | 16,439,136.58 | 16,439,136.58 | 16,439,136.58 | 16,439,136.58 |
| 其他非流动金融资产 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 |
| 投资性房地产 | 27,357,645.05 | 27,756,056.17 | 28,157,954.29 | 24,242,436.96 |
| 固定资产 | 913,357,206.1 | 919,462,658.28 | 928,036,154.63 | 913,526,432.9 |
| 在建工程 | 57,314,716.64 | 53,459,580.97 | 51,663,542.31 | 65,626,155.19 |
| 生产性生物资产 | 684,205.25 | 690,079.31 | 687,601.22 | 703,892.63 |
| 使用权资产 | 4,636,142.35 | 5,359,536.51 | 5,270,889.94 | 8,346,280.54 |
| 无形资产 | 94,100,120.04 | 95,399,783.93 | 97,614,829.24 | 101,154,336.86 |
| 开发支出 | 1,866,800 | 2,432,000 | 2,447,600 | 2,000,400 |
| 商誉 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 |
| 长期待摊费用 | 4,153,806.35 | 4,060,442.31 | 1,414,205.7 | 2,037,684.03 |
| 递延所得税资产 | 17,320,562.12 | 16,112,115.57 | 15,809,006.5 | 15,430,608.66 |
| 其他非流动资产 | 14,415,273.34 | 9,586,082.25 | 7,274,104.22 | 7,950,070.21 |
| 非流动资产合计 | 1,378,014,919.53 | 1,413,692,579.05 | 1,409,587,121.86 | 1,408,544,334.14 |
| 资产总计 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 | 2,597,696,324.22 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | - | - | - |
| 应付票据及应付账款 | 340,714,790.83 | 366,403,527.5 | 349,460,610.26 | 373,680,694.62 |
| 应付账款 | 340,714,790.83 | 366,403,527.5 | 349,460,610.26 | 373,680,694.62 |
| 预收款项 | 336,165.32 | - | 407,867.36 | 19,784 |
| 合同负债 | 9,328,249.18 | 27,491,120.34 | 7,585,152.51 | 13,025,753.55 |
| 应付职工薪酬 | 23,133,485.55 | 19,944,887.3 | 34,517,301.46 | 24,493,103.67 |
| 应交税费 | 27,390,657.26 | 29,100,717.83 | 28,666,764.44 | 29,408,679.75 |
| 其他应付款合计 | 92,264,001.47 | 95,390,885.09 | 96,421,756.48 | 89,774,645.16 |
| 一年内到期的非流动负债 | 2,349,983.39 | 2,538,116.84 | 2,538,116.84 | 6,238,680.28 |
| 其他流动负债 | 985,761.75 | 1,318,948.47 | 983,254.09 | 1,501,641.32 |
| 流动负债合计 | 506,503,094.75 | 542,188,203.37 | 520,580,823.44 | 538,142,982.35 |
| 非流动负债: | | | | |
| 长期借款 | 78,102,717.5 | 69,652,200 | 59,644,700 | 59,640,230 |
| 租赁负债 | 1,428,092.2 | 1,007,710.05 | 1,714,414.38 | 340,296.69 |
| 递延收益 | 42,267,112.04 | 43,406,139.49 | 44,895,813.26 | 46,385,487.14 |
| 递延所得税负债 | 6,618,282.86 | 7,014,536.39 | 7,358,097.69 | 7,733,723.53 |
| 非流动负债合计 | 128,416,204.6 | 121,080,585.93 | 113,613,025.33 | 114,099,737.36 |
| 负债合计 | 634,919,299.35 | 663,268,789.3 | 634,193,848.77 | 652,242,719.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 228,218,618 | 190,182,182 | 190,182,182 | 190,182,182 |
| 资本公积 | 472,009,459.76 | 510,045,895.76 | 510,045,895.76 | 505,930,291.23 |
| 盈余公积 | 97,154,751.67 | 97,154,751.67 | 97,154,751.67 | 97,154,751.67 |
| 未分配利润 | 1,042,711,629.45 | 1,047,018,455.94 | 1,011,561,158.96 | 1,005,683,946.87 |
| 归属于母公司股东权益合计 | 1,840,094,458.88 | 1,844,401,285.37 | 1,808,943,988.39 | 1,798,951,171.77 |
| 少数股东权益 | 139,568,691.94 | 142,655,464.74 | 142,688,103.25 | 146,502,432.74 |
| 股东权益合计 | 1,979,663,150.82 | 1,987,056,750.11 | 1,951,632,091.64 | 1,945,453,604.51 |
| 负债和股东权益合计 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 | 2,597,696,324.22 |
| 公告日期 | 2026-08-29 | 2026-04-28 | 2026-04-28 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |